We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$188M
AUM Growth
+$30.7M
Cap. Flow
+$18.4M
Cap. Flow %
9.8%
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73

Top Buys

Rank Stock Value
1
TCPC icon
BlackRock TCP Capital
TCPC
+$1.06M
2
HST icon
Host Hotels & Resorts
HST
+$965K
3
PLTR icon
Palantir
PLTR
+$932K
4
PSA icon
Public Storage
PSA
+$920K
5
DFS
Discover Financial Services
DFS
+$865K

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$962K
2
PLD icon
Prologis
PLD
+$773K
3
BKNG icon
Booking.com
BKNG
+$734K
4
ETN icon
Eaton
ETN
+$720K
5
TEL icon
TE Connectivity
TEL
+$708K

Sector Composition

Rank Sector Weight
1 Healthcare 21.52%
2 Financials 20.16%
3 Technology 16.46%
4 Industrials 8.76%
5 Energy 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
326
DELISTED
Merus
MRUS
$154K 0.08%
3,431
-231
-6% -$9.37K
SID icon
327
Companhia Siderúrgica Nacional
SID
$1.37B
$152K 0.08%
+48,556
New +$168K
NFE icon
328
New Fortress Energy
NFE
$92.9M
$151K 0.08%
+4,949
New +$163K
BLUE
329
DELISTED
bluebird bio
BLUE
$148K 0.08%
5,773
+831
+17% +$21.3K
BTG icon
330
B2Gold
BTG
$4.98B
$146K 0.08%
55,862
-9,315
-14% -$25.2K
BCYC
331
Bicycle Therapeutics
BCYC
$269M
$144K 0.08%
5,774
-398
-6% -$8.45K
VALE icon
332
Vale
VALE
$62.3B
$143K 0.08%
+11,737
New +$158K
ALLO icon
333
Allogene Therapeutics
ALLO
$625M
$143K 0.08%
31,967
-2,196
-6% -$9.16K
NRIX icon
334
Nurix Therapeutics
NRIX
$2.45B
$142K 0.08%
9,693
-663
-6% -$7.13K
MGNX icon
335
MacroGenics
MGNX
$233M
$137K 0.07%
9,309
-635
-6% -$9.6K
KYMR icon
336
Kymera Therapeutics
KYMR
$8.66B
$137K 0.07%
3,407
-231
-6% -$8.27K
SMMT icon
337
Summit Therapeutics
SMMT
$10.2B
$136K 0.07%
32,815
-2,254
-6% -$8.96K
MLYS icon
338
Mineralys Therapeutics
MLYS
$2.32B
$136K 0.07%
10,501
-721
-6% -$8.9K
KRYS icon
339
Krystal Biotech
KRYS
$10.7B
$132K 0.07%
744
-52
-7% -$7.22K
ORIC icon
340
Oric Pharmaceuticals
ORIC
$1.17B
$130K 0.07%
9,437
-648
-6% -$7.7K
GERN icon
341
Geron
GERN
$898M
$129K 0.07%
39,205
-2,687
-6% -$6.02K
IGMS
342
DELISTED
IGM Biosciences
IGMS
$129K 0.07%
13,332
-911
-6% -$10.6K
BHVN icon
343
Biohaven
BHVN
$2.02B
$126K 0.07%
2,303
-156
-6% -$7.72K
BMN icon
344
BlackRock 2037 Municipal Target Term Trust
BMN
$157M
$123K 0.07%
5,083
+1,813
+55% +$43.5K
PTGX icon
345
Protagonist Therapeutics
PTGX
$8.55B
$121K 0.06%
4,175
-282
-6% -$7.67K
ACLX
346
DELISTED
Arcellx
ACLX
$117K 0.06%
1,688
-117
-6% -$7.42K
COGT icon
347
Cogent Biosciences
COGT
$6.76B
$117K 0.06%
17,467
-1,199
-6% -$7.41K
CRNX icon
348
Crinetics Pharmaceuticals
CRNX
$8.88B
$116K 0.06%
2,479
-175
-7% -$6.85K
IBRX icon
349
ImmunityBio
IBRX
$7.15B
$114K 0.06%
21,290
-1,457
-6% -$6.6K
IDYA icon
350
IDEAYA Biosciences
IDYA
$3.43B
$111K 0.06%
2,535
-170
-6% -$7.31K
12 13
14
15 16

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Virtus ETF Advisers held 495 positions worth $188M, up 19% from $158M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $18.4M of net new capital in Q1 2024, opening 69 new positions and adding to 189 existing holdings. Its largest new stake was Host Hotels & Resorts: 47,997 shares worth $993K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was ConocoPhillips, an estimated $569K trimmed.

  • Virtus ETF Advisers's largest Q1 2024 buy was Host Hotels & Resorts: 47,997 shares worth $993K.
  • Virtus ETF Advisers added most to BlackRock TCP Capital in Q1 2024, an estimated $1.06M increase.
  • Virtus ETF Advisers's biggest Q1 2024 reduction was ConocoPhillips, cutting an estimated $569K.
  • Virtus ETF Advisers fully exited Burlington in Q1 2024, selling an estimated $962K.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $188M portfolio in Q1 2024.
  • Virtus ETF Advisers opened 69 new positions and closed 73 in Q1 2024.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $188M.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.